- Global Pharma News & Resources

Anti-Parkinson’s Drugs Market 2019 Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024

Market Research Engine has published a new report titled asAnti-Parkinson’s Drugs Market Size, By Product (Dopaminergic, Dopamine Agonist, Enzyme Inhibitors), By Region, Market Analysis Report, Forecast 2018-2024.”

Report scope:

The global anti-parkinson’s drugs market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.

The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies. 

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, GlaxoSmithKline, Mylan Labs, Novartis, Valeant Pharmaceuticals, and Zambon Pharmaceuticals.

Browse Full Report:

Rising political support from both state and national governments for funding in research activities and providing subsidies along with tax waivers is escalating the anti-parkinson’s drugs market size over the foreseeable time line. Additionally, upsurge in public awareness, ageing population, and rising health insurance will further promote in industry revenue generation till 2024.

Technological advancements such as 3-D printing solutions, wearable technologies, mobile applications, and biomarkers for monitoring and treating patients diagnosed with Parkinson’s disease will aid in enhancing the industry share between 2018 and 2024. Over 10 million of the population across the globe gets diagnosed with Parkinson's disease annually of which approximately 60,000 are Americans. Thus, rising prevalence of the Parkinson’s disease will improve the industry size.

Global anti-parkinson’s drugs market is segmented based on the product as, Dopaminergic, Dopamine Agonist, and Enzyme Inhibitors. Global anti-parkinson’s drugs market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional anti-parkinson’s drugs market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Competitive Rivalry

Global anti-parkinson’s drugs market share consists of several players AbbVie, GlaxoSmithKline, Mylan Labs, Novartis, Valeant Pharmaceuticals, and Zambon Pharmaceuticals.

The Anti-Parkinson’s Drugs Market has been segmented as below:

Anti-Parkinson’s Drugs Market Research, By Product

  • Dopaminergic
  • Dopamine Agonist
  • Enzyme Inhibitors
  • Others

Anti-Parkinson’s Drugs Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • Global anti-parkinson’s drugs market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
  • Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global anti-parkinson’s drugs market trends, with detailed analysis on consumer trends & manufacturer trends
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe
  • Competitive analysis of the industry players along with the overview on strategic management
  • Comprehensive company profiles of the major industry players

Reasons to Buy this Report:

  • Gain comprehensive insights on the industry trends
  • Identify industry opportunities and key growth segments
  • Obtain complete market study on the anti-parkinson’s drugs market
  • Facilitate strategy planning for your company based on the industry dynamics
  • Evaluate your competitor’s business segments and portfolios

Request Sample Report from here:

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Government initiatives
            4.2.2.    Major associations
        4.3.    Restraints
            4.3.1.    Shortage of skills
            4.3.2.    Stringent regulations and long approval procedures
        4.4.    Opportunities
            4.4.1.    Technological advancements
            4.4.2.    Internet penetration and mobile applications
        4.5.    Challenges
            4.5.1.    Existence of traditional medicines
  5.  Anti-Parkinson’s Drugs Market, By Product
  6.  Competitive Landscape
  7.  Company Profile
     7.1.    AbbVie
            7.1.1.    Company Overview
            7.1.2.    Product/Service Landscape
            7.1.3.    Financial Overview
            7.1.4.    Recent Developments
        7.2.    GlaxoSmithKline
            7.2.1.    Company Overview
            7.2.2.    Product/Service Landscape
            7.2.3.    Financial Overview
            7.2.4.    Recent Developments
        7.3.    Mylan Labs
            7.3.1.    Company Overview
            7.3.2.    Product/Service Landscape
            7.3.3.    Financial Overview
            7.3.4.    Recent Developments
        7.4.    Novartis
            7.4.1.    Company Overview
            7.4.2.    Product/Service Landscape
            7.4.3.    Financial Overview
            7.4.4.    Recent Developments
        7.5.    Valeant Pharmaceuticals
            7.5.1.    Company Overview
            7.5.2.    Product/Service Landscape
            7.5.3.    Financial Overview
            7.5.4.    Recent Developments
        7.6.    Zambon Pharmaceuticals
            7.6.1.    Company Overview
            7.6.2.    Product/Service Landscape
            7.6.3.    Financial Overview
            7.6.4.    Recent Developments

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States


Editor Details

Related Links

Last Updated: 18-Jun-2019